Last reviewed · How we verify

NCT04628156: CPPain

Chronic Pain In a Greek Population With Cerebral Palsy

Status unknown Last updated 16 November 2020
What this trial tests

trial in Cerebral Palsy in 150 participants. Status unknown.

Timeline
16 November 2020
Primary endpoint
15 February 2021
20 March 2021

Quick facts

Lead sponsorCerebral Palsy Greece - Open Door
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment150
Start date16 November 2020
Primary completion15 February 2021
Estimated completion20 March 2021
Sites1 location across Greece

Conditions studied

Sponsor

Cerebral Palsy Greece - Open Door

Who can join

Adults 5 to 58, any sex, with Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this observational, cross-sectional study is to effectuate a survey of chronic pain in a population of children, adolescents and adults with various forms of cerebral palsy in an educational and therapeutic setting in Athens, Greece. (Cerebral Palsy Greece-Open Door) Prevalence, intensity and localisation of pain will be associated to factors related to the functional and communicative limitations of the study's participants. The study also examines the agreement rate between different information sources and evaluation levels of chronic pain assessment in cerebral palsy (self-reports, caregiver questionnaires, observational check-lists administered by rehabilitation professionals, clinical evaluations by experts). A further research aim is to identify behavioural markers of chronic pain in individuals with cerebral palsy and a very limited communicative level.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04628156.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing